Human Insulin (INS) Advanced Assay Kit

In the diabetes management, accurate and timely insulin detection is crucial. Poclight presents an innovative insulin detection assay kit, utilizing the cutting-edge homogeneous chemiluminescent immunoassay method based on Chemiluminescence Resonance Energy Transfer (CRET) technology. This dual-site ("sandwich") assay leverages the strong chemiluminescent (CL) signal generated by acridinium ester (AE) in the presence of H2O2, providing a reliable solution for glucose monitoring.

Insulin CLIA kits - (Chemiluminescence Immuno Assay)

One of the standout features of Poclight's assay is its simplicity, enabling direct detection with unmatched convenience. This means that anyone can perform the test without the need for specialized training, ensuring consistent and reliable results every time.

Time is of the essence in medical diagnostics, and Poclight's insulin detection kit delivers results in just 5 minutes. This rapid turnaround time allows healthcare providers to make quick decisions, ultimately improving patient care. Additionally, the portability of Poclight's device cannot be overlooked—it is lightweight and compact, roughly the size of an A4 sheet, making it easy to transport and use in various settings.

Cost-effectiveness is another critical advantage of Poclight's insulin assay kit. With significantly reduced testing costs. Furthermore, Poclight's assay boasts a high level of standardization. Each kit contains single-use lyophilized reagent balls that can be stored at room temperature for 18-36 months, eliminating the need for refrigeration and minimizing risks associated with transport and storage.

Poclight's insulin detection assay kit represents a significant advancement in diabetes management. With its user-friendly operation, rapid results, portability, cost-effectiveness, and high standardization, it is set to transform the way insulin levels are monitored. 

当前网速较慢或者你使用的浏览器不支持博客特定功能,请尝试刷新或换用Chrome、Firefox等现代浏览器